Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells

Cancer Cell International

Wen-Ying Wu²  Xi-Jing Wang⁴  Wei-Li Min⁴  Xiao-Bin Ma⁴  Hua-Feng Kang⁴  Jie Gao³  Wang-Feng Lu⁴  Wei Tang¹  Zhi-Jun Dai⁴ 

[1] Department of life science, Shaanxi Normal University, Xi’an, 710061, China;Department of Pharmacology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China;Department of Nephrology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China;Department of Oncology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China

关键词: FasL;    Fas;    Apoptosis;    β-elemene;    Hepatoma;   

Others  :  794139
DOI  :  10.1186/1475-2867-13-27

 received in 2013-01-17, accepted in 2013-03-08,  发布年份 2013

【 摘 要 】

Background

β-elemene, a natural sesquiterpene extracted from the essential oils of Curcuma aromatica Salisb, has been shown to be effective against a wide range of tumors. In this study, the antitumor effect of β-elemene on a human hepatoma cell line, HepG2, and the mechanism involved have been investigated.

Methods

MTT assay was used to determine the growth inhibition of hepatoma HepG2 cells in vitro. Apoptosis of HepG2 cells were demonstrated by fluorescence microscope with Hoechst 33258 staining and flow cytometry with Annexin V-FITC/PI double staining. Flow cytometry was performed to analyze the cell cycle distribution of HepG2 cells. The mRNA and protein expression of Fas and FasL were measured by RT-PCR and Western blot analysis.

Results

MTT results showed that β-elemene could inhibit the proliferation of HepG2 cells in a time- and dose- dependent manner. Our results showed β-elemene had positive effect on apoptosis through fluorescence microscope and flow cytometry assay. Furthermore, β-elemene could induce the cell cycle arrest of the HepG2 cells in the G₂/M phase. Fas and FasL expression were obviously increased after β-elemene treatment in both mRNA and protein level.

Conclusion

The present study indicates that β-elemene can effectively inhibit proliferation and induce apoptosis in hepatoma HepG2 cells, and the apoptosis induction is related with up-regulating of Fas/FasL expression.

【 授权许可】

   
2013 Dai et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
• [2]Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M: Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 2011, 21:401-416.
• [3]Maluccio M, Covey A: Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 2012, 62:394-399.
• [4]Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-390.
• [5]Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009, 10:25-34.
• [6]Cao H, Phan H, Yang LX: Improved chemotherapy for hepatocellular carcinoma. Anticancer Res 2012, 32:1379-1386.
• [7]Yu JQ, Liu HB, Lei JC, Tan WJ, Hu XM, Zou GL: Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res 2007, 21:817-822.
• [8]Vickers A: Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 2002, 20:1069-1079.
• [9]Dai ZJ, Gao J, Li ZF, Ji ZZ, Kang HF, Guan HT, Diao Y, Wang BF, Wang XJ: In Vitro and In Vivo antitumor activity of Scutellaria Barbate extract on murine liver cancer. Molecules 2011, 16:4389-4400.
• [10]Yu ZH, Wei PK, Xu L, Qin ZF, Shi J: Anticancer effect of jinlongshe granules on in situ-transplanted human MKN-45 gastric cancer in nude mice and xenografted sarcoma 180 in Kunming mice and its mechanism. World J Gastroenterol 2006, 12:2890-2894.
• [11]Gupta S: Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int J Oncol 2003, 22:15-20.
• [12]Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL, Liles GB, Lee JR, Liu K: NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem 2012, 287:25530-25540.
• [13]Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX, Wu WY, Kang HF, Guan HT: Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol 2009, 123:91-96.
• [14]Lu JJ, Dang YY, Huang M, Xu WS, Chen XP, Wang YT: Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae. J Ethnopharmacol 2012, 143:406-411.
• [15]Zhang R, Tian A, Zhang H, Zhou Z, Yu H, Chen L: Amelioration of experimental autoimmune encephalomyelitis by beta-elemene treatment is associated with Th17 and Treg cell balance. J Molecular Neuroscience 2011, 44:31-40.
• [16]Wang B, Peng XX, Sun R, Li J, Zhan XR, Wu LJ, Wang SL, Xie T: Systematic review of β-Elemene injection as adjunctive treatment for lung cancer. Chin J Integr Med 2012, 18:813-823.
• [17]Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, Coad JE, Flynn DC, Reed E, Li QQ: Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 2005, 62:881-893.
• [18]Zhang B, Zhang X, Tang B, Zheng P, Zhang Y: Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression. Breast Cancer Res Treat 2012, 136:399-406.
• [19]Li QQ, Wang G, Huang F, Banda M, Reed E: Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J Pharm Pharmacol 2010, 62:1018-1027.
• [20]Liu J, Zhang Y, Qu J, Xu L, Hou K, Zhang J, Qu X, Liu Y: β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer 2011, 11:183. BioMed Central Full Text
• [21]Li X, Wang G, Zhao J, Ding H, Cunningham C, Chen F, Flynn DC, Reed E, Li QQ: Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci 2005, 62:894-904.
• [22]Liang D, Yang M, Guo B, Yang L, Cao J, Zhang X: HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis. J Cancer Res Clin Oncol 2012, 138:1865-1887.
• [23]Dai ZJ, Ma XB, Kang HF, Gao J, Min WL, Guan HT, Diao Y, Lu WF, Wang XJ: Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in vitro and in vivo. Cancer Cell Int 2012, 12:53. BioMed Central Full Text
• [24]Guan HT, Xue XH, Dai ZJ, Wang XJ, Li A, Qin ZY: Downregulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity. World J Gastroenterol 2006, 12:2901-2907.
• [25]Tao L, Zhou L, Zheng L, Yao M: Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother Pharmacol 2006, 58:24-34.
• [26]Bao F, Qiu J, Zhang H: Potential role of β-elemene on histone H1 in the H22 ascites hepatoma cell line. Mol Med Report 2012, 6:185-190.
• [27]Liu J, Zhang Z, Gao J, Xie J, Yang L, Hu S: Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis. Front Med 2011, 5:101-105.
• [28]Zhao YS, Zhu TZ, Chen YW, Yao YQ, Wu CM, Wei ZQ, Wang W, Xu YH: Β-elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells. J Neurooncol 2012, 107:307-314.
• [29]Lee RX, Li QQ, Reed E: β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells. Anticancer Res 2012, 32:3103-3113.
• [30]Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ, Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett 2008, 264:127-134.
• [31]Liu J, Hu XJ, Jin B, Qu XJ, Hou KZ, Liu YP: β-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells. J Pharm Pharmacol 2012, 64:146-153.
• [32]Pinti M, Troiano L, Nasi M, Moretti L, Monterastelli E, Mazzacani A, Mussi C, Ventura P, Olivieri F, Franceschi C, Salvioli G, Cossarizza A: Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death Differ 2002, 9:431-438.
• [33]Fumarola C, Guidotti GG: Stress-induced apoptosis: toward a symmetry with receptor mediated cell death. Apoptosis 2004, 9:77-82.
• [34]Zhao J, Li QQ, Zou B, Wang G, Li X, Kim JE, Cuff CF, Huang L, Reed E, Gardner K: In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma. Int J Oncol 2007, 31:241-252.